日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Covalent Inhibition of the Peptidyl-Prolyl Isomerase Pin1 by Sulfopin Results in a Broad Impact on the Phosphoproteome of Human Osteosarcoma U2-OS Cells.

磺酰肽对肽基脯氨酰异构酶 Pin1 的共价抑制作用对人类骨肉瘤 U2-OS 细胞的磷酸化蛋白质组产生广泛影响

Roffey Scott E, Hovey Owen, Jurcic Kristina, Lu Kun Ping, Zhou Xiao Zhen, Litchfield David W

Novel Pannexin 1 isoform is increased in cancer

癌症中新型 Pannexin 1 亚型增加

O'Donnell, Brooke L; Stefan, Dan; Chiu, Yu-Hsin; Zeitz, Michael J; Tang, Justin; Johnston, Danielle; Leighton, Stephanie E; Van Kessel, Carlijn; Barr, Kevin; Gyenis, Laszlo; Freeman, Taylor J; Kelly, John J; Sayedyahossein, Samar; Isakson, Brant E; Litchfield, David W; Roth, Kathryn; Smyth, James W; Hebb, Matthew; Ronald, John; Bayliss, Douglas A; Penuela, Silvia

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines

AKT通路参与三阴性乳腺癌细胞系对厄洛替尼和卡博替尼的耐药性

Lefebvre, Cory; Pellizzari, Sierra; Bhat, Vasudeva; Jurcic, Kristina; Litchfield, David W; Allan, Alison L

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2

利用定量磷酸化蛋白质组学比较 CX-4945 和 SGC-CK2-1 作为 CSNK2 抑制剂的疗效:三重 SILAC 联合抑制剂耐药性 CSNK2

Menyhart, Daniel; Gyenis, Laszlo; Jurcic, Kristina; Roffey, Scott E; Puri, Aakshi; Jovanovic, Predrag; Szkop, Krzysztof J; Pittock, Paula; Lajoie, Gilles; Axtman, Alison D; Larsson, Ola; Topisirovic, Ivan; Litchfield, David W

CSNK2 in cancer: pathophysiology and translational applications

CSNK2在癌症中的作用:病理生理学和转化应用

Strum, Scott W; Gyenis, Laszlo; Litchfield, David W

CK2 Regulation: Perspectives in 2021

CK2调控:2021年展望

Roffey, Scott E; Litchfield, David W

Correction for St-Denis et al., "Evidence for Regulation of Mitotic Progression through Temporal Phosphorylation and Dephosphorylation of CK2α"

对 St-Denis 等人的论文“通过 CK2α 的时间性磷酸化和去磷酸化调控有丝分裂进程的证据”的更正

St-Denis, Nicole A; Derksen, D Richard; Litchfield, David W

GAR22β regulates cell migration, sperm motility, and axoneme structure

GAR22β 调控细胞迁移、精子运动和轴丝结构

Gamper, Ivonne; Fleck, David; Barlin, Meltem; Spehr, Marc; El Sayad, Sara; Kleine, Henning; Maxeiner, Sebastian; Schalla, Carmen; Aydin, Gülcan; Hoss, Mareike; Litchfield, David W; Lüscher, Bernhard; Zenke, Martin; Sechi, Antonio

Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2

无偏倚功能蛋白质组学策略用于蛋白激酶抑制剂验证和鉴定真正的蛋白激酶底物:应用于鉴定EEF1D作为CK2的底物

Gyenis, Laszlo; Duncan, James S; Turowec, Jacob P; Bretner, Maria; Litchfield, David W

Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1

发现 PF-04620110,一种强效、选择性、口服生物可利用的 DGAT-1 抑制剂

Robert L Dow, Jian-Cheng Li, Michael P Pence, E Michael Gibbs, Jennifer L LaPerle, John Litchfield, David W Piotrowski, Michael J Munchhof, Tara B Manion, William J Zavadoski, Gregory S Walker, R Kirk McPherson, Susan Tapley, Eliot Sugarman, Angel Guzman-Perez, Paul DaSilva-Jardine